By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer
Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediate...
Gespeichert in:
Veröffentlicht in: | Oncotarget 2015-06, Vol.6 (18), p.16461-16470 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 16470 |
---|---|
container_issue | 18 |
container_start_page | 16461 |
container_title | Oncotarget |
container_volume | 6 |
creator | Zhang, Qing Song, Yanyan Chen, Wei Wang, Xiaohui Miao, Zhifeng Cao, Liu Li, Feng Wang, Guiling |
description | Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer. |
doi_str_mv | 10.18632/oncotarget.3889 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMottTuXeYHWJvnJNkIdapWqBREcRkymTtjpJ0ZkqnQf2-14uNuzoXD-RYfQueUXFKdcTZtG9_2LtbQX3KtzREaUiPMhEnJj__8AzRO6Y3sTwqlmTlFA5YRo5USQzS_3uEIPm5DH5oaL-aznF7gh9VjznDadl2ElCDhjtEXV9FpHjqKQ4Nrl_oYPPau8RDP0Enl1gnG3zlCz7c3T_lislzd3eez5cQLkvUTrg0FL7wGzY3LZFn50pWuUIpoITJhqIJCsUKCLERFCiaVkY5qoKrkUpd8hK4O3G5bbKD00PTRrW0Xw8bFnW1dsP-bJrzaun23QhrDNNsDyAHgY5tShOpnS4n9kmp_pdpPqfwDY0prGg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</creator><creatorcontrib>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</creatorcontrib><description>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.3889</identifier><identifier>PMID: 26098774</identifier><language>eng</language><publisher>Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2015-06, Vol.6 (18), p.16461-16470</ispartof><rights>Copyright: © 2015 Zhang et al. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</citedby><cites>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599282/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599282/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Zhang, Qing</creatorcontrib><creatorcontrib>Song, Yanyan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wang, Xiaohui</creatorcontrib><creatorcontrib>Miao, Zhifeng</creatorcontrib><creatorcontrib>Cao, Liu</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Wang, Guiling</creatorcontrib><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><title>Oncotarget</title><description>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMottTuXeYHWJvnJNkIdapWqBREcRkymTtjpJ0ZkqnQf2-14uNuzoXD-RYfQueUXFKdcTZtG9_2LtbQX3KtzREaUiPMhEnJj__8AzRO6Y3sTwqlmTlFA5YRo5USQzS_3uEIPm5DH5oaL-aznF7gh9VjznDadl2ElCDhjtEXV9FpHjqKQ4Nrl_oYPPau8RDP0Enl1gnG3zlCz7c3T_lislzd3eez5cQLkvUTrg0FL7wGzY3LZFn50pWuUIpoITJhqIJCsUKCLERFCiaVkY5qoKrkUpd8hK4O3G5bbKD00PTRrW0Xw8bFnW1dsP-bJrzaun23QhrDNNsDyAHgY5tShOpnS4n9kmp_pdpPqfwDY0prGg</recordid><startdate>20150630</startdate><enddate>20150630</enddate><creator>Zhang, Qing</creator><creator>Song, Yanyan</creator><creator>Chen, Wei</creator><creator>Wang, Xiaohui</creator><creator>Miao, Zhifeng</creator><creator>Cao, Liu</creator><creator>Li, Feng</creator><creator>Wang, Guiling</creator><general>Impact Journals LLC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20150630</creationdate><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><author>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Qing</creatorcontrib><creatorcontrib>Song, Yanyan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wang, Xiaohui</creatorcontrib><creatorcontrib>Miao, Zhifeng</creatorcontrib><creatorcontrib>Cao, Liu</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Wang, Guiling</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Qing</au><au>Song, Yanyan</au><au>Chen, Wei</au><au>Wang, Xiaohui</au><au>Miao, Zhifeng</au><au>Cao, Liu</au><au>Li, Feng</au><au>Wang, Guiling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</atitle><jtitle>Oncotarget</jtitle><date>2015-06-30</date><risdate>2015</risdate><volume>6</volume><issue>18</issue><spage>16461</spage><epage>16470</epage><pages>16461-16470</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</abstract><pub>Impact Journals LLC</pub><pmid>26098774</pmid><doi>10.18632/oncotarget.3889</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2015-06, Vol.6 (18), p.16461-16470 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals |
subjects | Research Paper |
title | By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A16%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=By%20recruiting%20HDAC1,%20MORC2%20suppresses%20p21Waf1/Cip1%20in%20gastric%20cancer&rft.jtitle=Oncotarget&rft.au=Zhang,%20Qing&rft.date=2015-06-30&rft.volume=6&rft.issue=18&rft.spage=16461&rft.epage=16470&rft.pages=16461-16470&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.3889&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26098774&rfr_iscdi=true |